Literature DB >> 8794797

Distribution of alkaline sphingomyelinase activity in human beings and animals. Tissue and species differences.

R D Duan1, E Hertervig, L Nyberg, T Hauge, B Sternby, J Lillienau, A Farooqi, A Nilsson.   

Abstract

The alkaline sphingomyelinase (SMase) was first found in rat intestinal brush border. The important roles of this enzyme in digestion of sphingomyelin and in mucosal cell proliferation have been suggested. In the present work, the distribution of the alkaline SMase in the tissues of human beings and animals have been studied. By assaying the enzyme activity in human biopsy samples, we found that the alkaline SMase activity was absent in the stomach, increased in the duodenum, present at high levels in the small intestine, and slightly declined in the colon and rectum. High activities were found similarly in the intestinal contents of the healthy adults and infants. The activities were also found in the intestinal mucosa of rats, normal and germ-free mice, and hamsters with the same distribution pattern as in humans, but not in the intestinal mucosa of guinea pigs. Apart from the intestinal tract, a SMase activity preferring alkaline pH was identified in human and guinea pig bile, but not in the bile of rat, pig, sheep, and cow. No activity was found in either pancreatic tissue or pancreatic juice in all species tested, and none was detected in human urine and milk. In conclusion, alkaline SMase exists predominantly in the digestive system with considerable tissue and species differences.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794797     DOI: 10.1007/bf02088748

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Chemical synthesis of choline-labeled lecithins and sphingomyelins.

Authors:  W Stoffel
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Magnesium-dependent sphingomyelinase of infantile brain. Effect of detergents and a heat-stable factor.

Authors:  S Gatt; T Dinur; Z Leibovitz-Ben Gershon
Journal:  Biochim Biophys Acta       Date:  1978-11-22

3.  The presence of spingomyelin- and ceramide-cleaving enzymes in the small intestinal tract.

Authors:  A Nilsson
Journal:  Biochim Biophys Acta       Date:  1969-03-04

4.  Signaling through the sphingomyelin pathway.

Authors:  Y Zhang; R Kolesnick
Journal:  Endocrinology       Date:  1995-10       Impact factor: 4.736

Review 5.  Human milk bile salt-stimulated lipase: functional and molecular aspects.

Authors:  O Hernell; L Bläckberg
Journal:  J Pediatr       Date:  1994-11       Impact factor: 4.406

6.  Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice.

Authors:  D L Dillehay; S K Webb; E M Schmelz; A H Merrill
Journal:  J Nutr       Date:  1994-05       Impact factor: 4.798

7.  Uptake and metabolism of sphingolipids in isolated intestinal loops of mice.

Authors:  E M Schmelz; K J Crall; R Larocque; D L Dillehay; A H Merrill
Journal:  J Nutr       Date:  1994-05       Impact factor: 4.798

Review 8.  Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids.

Authors:  Y A Hannun; C M Linardic
Journal:  Biochim Biophys Acta       Date:  1993-12-21

Review 9.  Neutral sphingomyelinase.

Authors:  S Chatterjee
Journal:  Adv Lipid Res       Date:  1993

Review 10.  Role of dietary sphingolipids and inhibitors of sphingolipid metabolism in cancer and other diseases.

Authors:  A H Merrill; E M Schmelz; E Wang; J J Schroeder; D L Dillehay; R T Riley
Journal:  J Nutr       Date:  1995-06       Impact factor: 4.798

View more
  27 in total

Review 1.  Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke.

Authors:  Tzipora Goldkorn; Simone Filosto
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-04       Impact factor: 6.914

Review 2.  Roles of cPLA2alpha and arachidonic acid in cancer.

Authors:  Masako Nakanishi; Daniel W Rosenberg
Journal:  Biochim Biophys Acta       Date:  2006-09-15

3.  Generating ceramide from sphingomyelin by alkaline sphingomyelinase in the gut enhances sphingomyelin-induced inhibition of cholesterol uptake in Caco-2 cells.

Authors:  Dan Feng; Lena Ohlsson; Wenhua Ling; Ake Nilsson; Rui-Dong Duan
Journal:  Dig Dis Sci       Date:  2010-12       Impact factor: 3.199

4.  Digestion of Ceramide 2-Aminoethylphosphonate, a Sphingolipid from the Jumbo Flying Squid Dosidicus gigas, in Mice.

Authors:  Nami Tomonaga; Yuki Manabe; Tatsuya Sugawara
Journal:  Lipids       Date:  2017-02-27       Impact factor: 1.880

Review 5.  The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.

Authors:  Eric L Smith; Edward H Schuchman
Journal:  FASEB J       Date:  2008-06-20       Impact factor: 5.191

Review 6.  Signal transduction of stress via ceramide.

Authors:  S Mathias; L A Peña; R N Kolesnick
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

7.  Expression of alkaline sphingomyelinase in yeast cells and anti-inflammatory effects of the expressed enzyme in a rat colitis model.

Authors:  David Andersson; Knut Kotarsky; Jun Wu; William Agace; Rui-Dong Duan
Journal:  Dig Dis Sci       Date:  2008-11-07       Impact factor: 3.199

8.  VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation.

Authors:  I Soo; K L Madsen; Q Tejpar; B C Sydora; R Sherbaniuk; B Cinque; L Di Marzio; M Grazia Cifone; C Desimone; R N Fedorak
Journal:  Can J Gastroenterol       Date:  2008-03       Impact factor: 3.522

9.  Reduction in alkaline sphingomyelinase in colorectal tumorigenesis is not related to the APC gene mutation.

Authors:  Erik Hertervig; Ake Nilsson; Mef Nilbert; Rui-Dong Duan
Journal:  Int J Colorectal Dis       Date:  2003-03-04       Impact factor: 2.571

10.  Development of intestinal alkaline sphingomyelinase in rat fetus and newborn rat.

Authors:  Jan Lillienau; Yajun Cheng; Ake Nilsson; Rui-Dong Duan
Journal:  Lipids       Date:  2003-05       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.